Previous studies revealed that ARHGEF5 regulates actin cytoskeletal dynamics by activating the RhoA-ROCK pathway, thereby promoting the migration and invasion of cancer cells (Kuroiwa et al., 2011; Lee et al., 2015; Komiya et al., 2016). This evidence concerns the gene ARHGEF5 and cancer.